Which venue approved new XRP ETF?

TLDR

Cboe BZX Exchange approved the listing of the new 21Shares XRP ETF (ticker TOXR), clearing it to list once final issuance steps are complete, per a Cboe filing update.

1. Listing approval is a green light to list; trading awaits final S?1 clearance per a recent report.
2. The funds sponsor fee is 0.30% with a multi?custodian setup, confirmed in a venue note.
3. It joins a U.S. XRP ETF lineup with inflows approaching $1 billion, per a market recap.

Deep Dive

1. Venue and Status

The venue is Cboe BZX Exchange, which approved the listing for TOXR; this is the exchanges readiness to host the product once issuer and SEC registration elements finalize, as noted in a listing approval report.

• The funds S?1 carries a delaying amendment, meaning administrative steps remain before shares begin trading, per coverage.

2. Product Details

21Shares TOXR tracks the CME CF XRP?Dollar Reference Rate (New York Variant), uses Coinbase Custody, Anchorage Digital Bank, and BitGo Trust Company, and charges 0.30% annually, confirmed in the venue detail.

• Ripple Markets seeded the ETF with 100 million XRP (about $226 million) to support initial liquidity, noted alongside the listing approval in the same update.

3. Market Context

U.S. spot XRP ETFs have sustained net inflows and are nearing $1 billion combined assets shortly after launch, indicating steady demand despite broader volatility, per a market recap.

• Adding TOXR increases choice and potentially deepens regulated liquidity for XRP exposure.

Conclusion

Answer: Cboe BZX Exchange approved the new XRP ETFs listing. This is a venue approval that enables listing, with trading to follow after final registration steps. The combination of a low fee, multi?custodian design, and growing sector inflows suggests a supportive structure for institutional participation over time.